BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35292786)

  • 1. Relationship of
    Asya O; Yumuşakhuylu AC; Bağcı P; Kaya H; Gönen A; Gündoğdu Y; Muradov T; Şahin A; Oysu Ç
    Acta Otorhinolaryngol Ital; 2022 Feb; 42(1):34-40. PubMed ID: 35292786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears.
    Ferraz C; Rehfeld C; Krogdahl A; Precht Jensen EM; Bösenberg E; Narz F; Hegedüs L; Paschke R; Eszlinger M
    Thyroid; 2012 Oct; 22(10):1025-30. PubMed ID: 23025542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms.
    Chia WK; Sharifah NA; Reena RM; Zubaidah Z; Clarence-Ko CH; Rohaizak M; Naqiyah I; Srijit D; Hisham AN; Asmiati A; Rafie MK
    Cancer Genet Cytogenet; 2010 Jan; 196(1):7-13. PubMed ID: 19963130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic binding of PAX8-PPARG fusion protein regulates cancer-related pathways and alters the immune landscape of thyroid cancer.
    Zhang Y; Yu J; Grachtchouk V; Qin T; Lumeng CN; Sartor MA; Koenig RJ
    Oncotarget; 2017 Jan; 8(4):5761-5773. PubMed ID: 28008156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases.
    Boos LA; Dettmer M; Schmitt A; Rudolph T; Steinert H; Moch H; Sobrinho-Simões M; Komminoth P; Perren A
    Histopathology; 2013 Aug; 63(2):234-41. PubMed ID: 23738683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein.
    Zhang Y; Yu J; Lee C; Xu B; Sartor MA; Koenig RJ
    Oncotarget; 2015 Dec; 6(38):40418-32. PubMed ID: 26595524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pax-8-PPAR-γ fusion protein in thyroid carcinoma.
    Raman P; Koenig RJ
    Nat Rev Endocrinol; 2014 Oct; 10(10):616-23. PubMed ID: 25069464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The thyroid cancer PAX8-PPARG fusion protein activates Wnt/TCF-responsive cells that have a transformed phenotype.
    Vu-Phan D; Grachtchouk V; Yu J; Colby LA; Wicha MS; Koenig RJ
    Endocr Relat Cancer; 2013 Oct; 20(5):725-39. PubMed ID: 24025583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
    Castro P; Rebocho AP; Soares RJ; Magalhães J; Roque L; Trovisco V; Vieira de Castro I; Cardoso-de-Oliveira M; Fonseca E; Soares P; Sobrinho-Simões M
    J Clin Endocrinol Metab; 2006 Jan; 91(1):213-20. PubMed ID: 16219715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipogenic Differentiation of Thyroid Cancer Cells Through the Pax8-PPARγ Fusion Protein Is Regulated by Thyroid Transcription Factor 1 (TTF-1).
    Xu B; O'Donnell M; O'Donnell J; Yu J; Zhang Y; Sartor MA; Koenig RJ
    J Biol Chem; 2016 Sep; 291(37):19274-86. PubMed ID: 27435678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis.
    Algeciras-Schimnich A; Milosevic D; McIver B; Flynn H; Reddi HV; Eberhardt NL; Grebe SK
    Clin Chem; 2010 Mar; 56(3):391-8. PubMed ID: 20056739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous occurrence of PAX8-PPARg and RET-PTC3 rearrangements in a follicular variant of papillary thyroid carcinoma.
    Caria P; Dettori T; Frau DV; Di Oto E; Morandi L; Parmeggiani A; Tallini G; Vanni R
    Am J Surg Pathol; 2012 Sep; 36(9):1415-20. PubMed ID: 22895275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.
    Nikiforova MN; Biddinger PW; Caudill CM; Kroll TG; Nikiforov YE
    Am J Surg Pathol; 2002 Aug; 26(8):1016-23. PubMed ID: 12170088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review.
    Şahpaz A; Önal B; Yeşilyurt A; Han Ü; Delibaşı T
    Balkan Med J; 2015 Apr; 32(2):156-66. PubMed ID: 26167339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation.
    Giordano TJ; Au AY; Kuick R; Thomas DG; Rhodes DR; Wilhelm KG; Vinco M; Misek DE; Sanders D; Zhu Z; Ciampi R; Hanash S; Chinnaiyan A; Clifton-Bligh RJ; Robinson BG; Nikiforov YE; Koenig RJ
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1983-93. PubMed ID: 16609007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.
    Banito A; Pinto AE; Espadinha C; Marques AR; Leite V
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):706-11. PubMed ID: 17651453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.
    Patel MR; Bryson PC; Shores CG; Hart CF; Thorne LB; Deal AM; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):590-6. PubMed ID: 19528408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing detection of RET and PPARg rearrangements in thyroid neoplastic cells using a home-brew tetracolor probe.
    Caria P; Frau DV; Dettori T; Boi F; Lai ML; Mariotti S; Vanni R
    Cancer Cytopathol; 2014 May; 122(5):377-85. PubMed ID: 24510380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
    Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
    Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.
    Bartolome A; Boskovic S; Paunovic I; Bozic V; Cvejic D
    APMIS; 2016 Apr; 124(4):271-7. PubMed ID: 26750533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.